查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092754

口服生技藥品及生物相似藥市場：依產品類型、應用、通路、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Oral Biologics & Biosimilars Market, By Product Type, By Application, By Distribution, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 418 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，口服生技藥品和生物相似藥市場價值將達到 879.03 億美元，並將在 2026 年至 2033 年期間以 15.8% 的複合年成長率成長。

口服生物製藥和生物相似藥市場包括生物製藥、生物相似藥和先進生物製藥，它們透過藥物遞送技術口服給藥，這些技術可防止藥物在胃腸道中分解並提高吸收率。與傳統的注射用生物製藥不同，口服生物製藥旨在提高使用便利性和治療依從性，並增強疾病的長期管理。

該產業涵蓋眾多類別，包括口服蛋白、胜肽類、單株抗體、荷爾蒙以及其他用於治療代謝性疾病、自體免疫疾病、胃腸道疾病、腫瘤、呼吸系統疾病和神經系統疾病的先進生物製藥。口服給藥系統、腸溶包衣、滲透增強劑和膠囊給藥系統的不斷進步，有助於高效遞送和吸收大分子化合物，從而推動市場成長。製藥公司與藥物遞送技術供應商之間的合作、生物相似藥研發的增加以及生物製藥產品線的拓展，也促進了市場成長。

口服生物製藥和生物相似藥市場—市場動態

口服生物製劑藥物傳遞技術的進展

口服藥物遞送技術的不斷創新是推動口服生物製藥和生物相似藥市場發展的關鍵因素之一。製藥公司正致力於開發基於膠囊的遞送機制、滲透性增強技術以及能夠保護蛋白質、胜肽和單株抗體醫藥品免受胃腸道分解的製劑。這些進展有望提高治療質量，並透過減少注射給藥的需求，使患者的生活更加便捷。例如，Rani Therapeutics 與 Chugai Pharmaceutical 於 2025 年 10 月達成合作，共同開發採用 RaniPill® 技術的口服抗體醫藥品。該協議價值高達 10.85 億美元。

口服生技藥品和生物相似藥市場－市場區隔分析：

全球口服生技藥品和生物相似藥市場按產品類型、應用、分銷和地區進行細分。

按產品類型分類，全球口服生物製藥和生物相似藥市場預計將由蛋白質和胜肽類藥物主導。這一成長得益於此類藥物在糖尿病、肥胖症和其他代謝性疾病治療中應用日益廣泛，以及口服給藥方式的不斷改進。此外，口服胜肽製劑的成功商業化增強了市場對該類別的信心，並為進一步拓展產品線鋪平了道路。根據諾和諾德2025年年度報告，Rybelsus®（口服Semaglutide）的總銷售額將在2025年達到237億丹麥克朗，這表明基於胜肽的口服製劑在醫生和患者中具有很高的接受度。隨著單株抗體藥物的口服給藥技術逐漸走向商業化，預計單株抗體類別將在未來成為口服生物製藥和生物相似藥市場的主要細分領域。

口服生物製藥和生物相似藥市場—區域分析

北美在該市場佔據最大的銷售佔有率。該地區強勁的生物製藥研發管線、慢性病高發以及旨在提高生物相似藥可及性的監管舉措，共同推動了市場成長。此外，美國食品藥物管理局(FDA) 積極參與生物相似藥的核准，並已提案減少相容生物相似藥的轉換試驗需求。歐洲預計也將繼續在口服生物製藥和生物相似藥領域佔據重要地位。這是因為歐洲藥品管理局 (EMA) 集中審查大多數生物相似藥申請，並為生物相似藥的研發提供科學建議。亞太地區預計將保持穩定成長，這主要得益於生物製藥產量的增加、政府對生物相似藥的指導方針，以及印度、中國、日本和韓國等國家先進療法的普及。

目錄

第1章：口服生技藥品和生物相似藥市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：口服生技藥品和生物相似藥的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：口服生技藥品與生物相似藥產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 口服生技藥品與生物相似藥市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：口服生技藥品和生物相似藥的市場趨勢

  • 2025年口服生技藥品及生物相似藥市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 口服生技藥品和生物相似藥市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 蛋白質和胜肽
    • 單株抗體
    • 荷爾蒙藥物
    • 其他

第8章 口服生技藥品和生物相似藥市場：依應用分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 代謝性疾病
    • 自體免疫疾病與發炎性疾病
    • 腫瘤學
    • 呼吸系統疾病
    • 神經病學
    • 消化系統疾病
    • 其他

第9章 口服生技藥品及生物相似藥市場：依通路分類

  • 概述
    • 基於細分市場的市場佔有率分析：按分銷管道分類
    • 醫院藥房
    • 零售藥房
    • 網路藥房

第10章 口服生技藥品及生物相似藥市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章 主要供應商分析：口服生技藥品與生物相似藥產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Novartis International AG
    • Rani Therapeutics Holdings Inc.
    • Eli Lilly and Company
    • AstraZeneca plc
    • Novo Nordisk A/S
    • Biocon Limited
    • Oramed Pharmaceuticals Inc.
    • BiosanaPharma
    • Entera Bio Ltd.
    • Enteris BioPharma Inc.
    • Chiesi Farmaceutici SpA
    • Sanofi SA
    • F. Hoffmann-La Roche Ltd.
    • Pfizer Inc.
    • Sandoz International GmbH
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV/Viatris Inc.
    • Amgen Inc.
    • Celltrion Inc.
    • Samsung Bioepis
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6957

Oral Biologics & Biosimilars Market size was valued at US$ 8,790.3 Million in 2025, expanding at a CAGR of 15.8% from 2026 to 2033.

The oral biologics & biosimilars market consists of biologics, biosimilars, and sophisticated biologics, which are used in oral delivery through drug delivery technologies that ensure protection against degradation in the gastrointestinal system and facilitate absorption. Unlike traditional injectable biologics, oral biologics have been formulated to increase ease of use and treatment adherence and for better disease management over a period of time.

The industry encompasses various categories such as oral proteins, peptides, monoclonal antibodies, hormones, and other sophisticated biologics, which have been formulated for the treatment of metabolic disorders, autoimmune disorders, gastrointestinal diseases, oncology, respiratory diseases, and neurological diseases. The market growth has been boosted by continuous advancements in oral delivery systems, enteric coatings, permeation enhancers, and capsule delivery systems, which help in efficient delivery and absorption of large molecules. Collaborations between pharmaceutical firms and drug delivery technology providers, increased biosimilar development, and expansion of biologics pipeline are contributing to growth.

Oral Biologics & Biosimilars Market- Market Dynamics

Advancements in oral biologic drug delivery technologies

Rising innovation in the technology of drug delivery via oral route is one of the primary drivers driving the market for oral biologics & biosimilars forward. Pharma companies are making efforts to invent capsule-based delivery mechanisms, permeation enhancing techniques, and formulations for the protection of protein, peptide, and monoclonal antibody drugs from destruction within the digestive tract. These developments have the potential to make life more convenient for patients and ensure improved treatment by reducing the requirement for administration through the injection route. An example of this is the collaboration of Rani Therapeutics with Chugai Pharmaceutical in October 2025 for the development of an oral antibody drug with the help of RaniPill(R) technology. The contract is worth up to USD 1.085 billion.

Oral Biologics & Biosimilars Market- Segmentation Analysis:

The Global Oral Biologics & Biosimilars Market is segmented on the basis of Product Type, Application, Distribution, and Region.

In terms of product type, the worldwide Oral Biologics & Biosimilars industry is estimated to be dominated by Proteins & Peptides segment. Growth is supported by the rising adoption of these drugs in the treatment of diabetes, obesity, and other metabolic diseases along with constant improvement in the methods of oral drug delivery. In addition, the successful commercialization of oral peptide drugs has instilled confidence in this category, and has paved the way for further pipeline expansion. As per Novo Nordisk's annual report of 2025, total revenue from Rybelsus(R) (oral semaglutide) in 2025 was worth DKK 23.7 billion, indicating high acceptance of peptide-based oral drugs among physicians and patients. Monoclonal Antibodies category is expected to be the future segment in oral biologics & biosimilars market as oral delivery technology of these drugs moves closer towards commercialization.

Oral Biologics & Biosimilars Market- Geographical Insights

North America region is accounted for the maximum revenue share in this market. Robust pipelines for biologics, high incidence of chronic diseases, and regulatory initiatives focused on enhancing biosimilar availability has supported the regional growth. Moreover, the U.S. FDA is actively involved in the approval of biosimilars, with proposals to reduce the need for switching studies for interchangeable biosimilars. Europe too will remain significant in the context of oral biologics & biosimilars, because the EMA centrally assesses majority of the biosimilars' application along with providing scientific advice on biosimilars development. Asia Pacific will see steady growth driven by growing biologics production, government biosimilar guidelines, and increased access to advanced treatments in countries like India, China, Japan, and South Korea.

Oral Biologics & Biosimilars Market- Competitive Landscape:

The global market is driven by strategic alliances among pharma companies and oral drug delivery platform developers. Top competitors such as Novo Nordisk, Eli Lilly and Company, Novartis, Sanofi, AstraZeneca, and Rani Therapeutics are making significant investments in novel oral delivery systems, peptide drugs, and new generation biologics to increase their product portfolio offerings.

Major players are increasingly interested in enhancing the bioavailability, gastrointestinal stability, and patient compliance of their products without being heavily dependent on injectable forms. Some of the important strategies used by these players include licensing and technology partnerships along with pipeline expansion initiatives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Novartis International AG
  • Rani Therapeutics Holdings Inc.
  • Eli Lilly and Company
  • AstraZeneca plc
  • Novo Nordisk A/S
  • Biocon Limited
  • Oramed Pharmaceuticals Inc.
  • BiosanaPharma
  • Entera Bio Ltd.
  • Enteris BioPharma Inc.
  • Chiesi Farmaceutici S.p.A.
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V. / Viatris Inc.
  • Amgen Inc.
  • Celltrion Inc.
  • Samsung Bioepis
  • Others

GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Proteins & Peptides
  • Monoclonal Antibodies
  • Hormones
  • Others

GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Metabolic Disorders
  • Autoimmune & Inflammatory Diseases
  • Oncology
  • Respiratory Diseases
  • Neurology
  • Gastrointestinal Disorders
  • Others

GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2020 - 2033

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Oral Biologics & Biosimilars Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Oral Biologics & Biosimilars Market Snippet by Product Type
    • 2.1.2. Oral Biologics & Biosimilars Market Snippet by Application
    • 2.1.3. Oral Biologics & Biosimilars Market Snippet by Distribution
    • 2.1.4. Oral Biologics & Biosimilars Market Snippet by Country
    • 2.1.5. Oral Biologics & Biosimilars Market Snippet by Region
  • 2.2. Competitive Insights

3. Oral Biologics & Biosimilars Key Market Trends

  • 3.1. Oral Biologics & Biosimilars Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Oral Biologics & Biosimilars Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Oral Biologics & Biosimilars Market Opportunities
  • 3.4. Oral Biologics & Biosimilars Market Future Trends

4. Oral Biologics & Biosimilars Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Oral Biologics & Biosimilars Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Oral Biologics & Biosimilars Market Landscape

  • 6.1. Oral Biologics & Biosimilars Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Oral Biologics & Biosimilars Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Proteins & Peptides
    • 7.1.3. Monoclonal Antibodies
    • 7.1.4. Hormones
    • 7.1.5. Others

8. Oral Biologics & Biosimilars Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Metabolic Disorders
    • 8.1.3. Autoimmune & Inflammatory Diseases
    • 8.1.4. Oncology
    • 8.1.5. Respiratory Diseases
    • 8.1.6. Neurology
    • 8.1.7. Gastrointestinal Disorders
    • 8.1.8. Others

9. Oral Biologics & Biosimilars Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2025 & 2033 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies

10. Oral Biologics & Biosimilars Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Oral Biologics & Biosimilars Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Oral Biologics & Biosimilars Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Oral Biologics & Biosimilars Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Oral Biologics & Biosimilars Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Oral Biologics & Biosimilars Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Oral Biologics & Biosimilars Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Novartis International AG
    • 11.2.2. Rani Therapeutics Holdings Inc.
    • 11.2.3. Eli Lilly and Company
    • 11.2.4. AstraZeneca plc
    • 11.2.5. Novo Nordisk A/S
    • 11.2.6. Biocon Limited
    • 11.2.7. Oramed Pharmaceuticals Inc.
    • 11.2.8. BiosanaPharma
    • 11.2.9. Entera Bio Ltd.
    • 11.2.10. Enteris BioPharma Inc.
    • 11.2.11. Chiesi Farmaceutici S.p.A.
    • 11.2.12. Sanofi S.A.
    • 11.2.13. F. Hoffmann-La Roche Ltd.
    • 11.2.14. Pfizer Inc.
    • 11.2.15. Sandoz International GmbH
    • 11.2.16. Teva Pharmaceutical Industries Ltd.
    • 11.2.17. Mylan N.V. / Viatris Inc.
    • 11.2.18. Amgen Inc.
    • 11.2.19. Celltrion Inc.
    • 11.2.20. Samsung Bioepis
    • 11.2.21. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us